Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorJohannes Gutenberg University Mainz
About this trial
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
clinical indication to coronary angiography
Disqualifiers
none
Trial population
Patients with clinical indication for coronary angiography.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
observational only- no intervention
Other intervention
Treatment groups
1,000 Participants
are divided into 1 treatment groupGroup A: Consecutive patients undergoing coronary angiography1 intervention
Trial outcomes
Primary outcomes
1
Major adverse cardiovascular events
Incidence of major adverse events (death, death of cardiac cause, TLR - target lesion revascularization, MI)
Time frame
baseline to 10 yearsSecondary outcomes
1
Individual endpoints
Each individual endpoint of the MACE previously described
Time frame
baseline to 10 years2
Other cardiovascular endpoints
TVR - target vessel revascularization, re-hospitalization, change in medications.
Time frame
baseline to 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov